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INTRODUCTION
Lung cancer is the most common cancer in the world (1)
and is the leading cause of cancer deaths in Korea (2). It is
estimated that lung cancer will continue to be the leading
cause of cancer deaths among Korean people for the next 20
yr (3, 4). 
While the epidemiological evidence linking smoking to
risk of lung cancer is extensive (5), there are several reports
that smoking is the important risk factor of lung cancer in
Koreans (4, 6, 7). However, studies by Kim et al. (4) and Jee
et al. (6) focused on mortality instead of the incidence of lung
cancer. And the baseline information for the study by Yun
et al. (7) as well as the previous two studies (4, 6) was obtained
from a secondary source constructed by a business program
of the National Health Insurance Corporation in spite of the
outcome as the incidence of lung cancer. In order to estimate
the magnitude of association between smoking and lung
cancer in Koreans more exactly, a population-based prospec-
tive cohort study with a focus on the cancer incidence using
a primary source was needed.
Thus, this study was designed to add to the body of knowl-
edge regarding smoking habits and lung cancer risk in Kore-
an men based on a population-based prospective cohort study.
MATERIALS AND METHODS
Study cohort
The study cohort was constructed from the Seoul Male
Cancer Cohort (SMCC), which has been partially reported
elsewhere (8-11). The criteria of the eligible population were
male beneficiaries of the Korea Medical Insurance Corpora-
tion (KMIC), confirmed to be healthy by the medical screen-
ing in 1990; aged between 40 and 59 yr in 1993; and living
in Seoul, the largest city in Korea. The KMIC included gov-
ernment employees, school teachers, and pensioners living
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Cigarette Smoking and Risk of Lung Cancer in Korean Men: 
The Seoul Male Cancer Cohort Study
Lung cancer is the leading cause of cancer deaths in Korea. The aim of this study
was to estimate lung cancer risk of cigarette smoking in Korean men by a 10-yr
follow-up prospective cohort study using the primary databases. The number of
subjects was 14,272 men, who had full information of smoking habits among par-
ticipants in the Seoul Male Cancer Cohort Study (SMCC). Total 125,053 person-
years were calculated by determining the number of days from the start of follow-
up, January 1, 1993, until the date of lung cancer diagnosis, death from another
cause, or the end of follow-up, December 31, 2002, followed by converting the num-
ber of days to years. The information of outcome was obtained by the database of
Korea Central Cancer Registry, Seoul Regional Cancer Registry, and Korea Sta-
tistical Office. The relative risk (RR) and its 95% confidence interval (CI) values of
smoking were calculated using Cox proportional hazards regression stratified on
potential confounders. During the follow-up periods, 78 cases of lung cancer occurr-
ed. The cigarette smoking is the major risk factor and increases the 4.18-fold risk
of lung cancer in Korean men. In order to control lung cancer, intervention of quit-
ting smoking is needed. 
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with their families since 1978. The nationwide total num-
ber of beneficiaries was around 4.7 million in 1992, which
is about 11% of the total Korean population. To assemble a
cohort size of at least 14,000 men, we mailed the self-admin-
istered questionnaire to 29,918 eligible papulation sampled at
leact three times in 1992. Finally, we received completed,
usable questionnaires having full information on smoking habits
from 14,272 men, giving a response rate of 47.7%. The age
distribution of this cohort was very similar to that of the Kore-
an population.
Follow-up was done over 10 yr from January 1, 1993 to
December 31, 2002 (Fig. 1). Incident cases of all cancers, in-
cluding lung cancer, occurring during the 10-yr follow up
period were identified through the database of Seoul Region-
al Cancer Registry as a population-based cancer registry (12,
13), the Korea Central Cancer Registry as a nationwide, hos-
pital-based, cancer registry (14), and death certificates in the
Korea Statistical Office (2).
Categorization of variables
While the never smoker was defined as a total consump-
tion in the whole life of less than 20 cigarettes, we classified
subjects by smoking status (never, past, or current), duration
of smoking (0, 1-10, 11-20, 21-30, or 31+ yr), daily amounts
of smoking (0, 1-10, 11-20, 21-30, or 31+ cigarettes/day),
and total cigarette index (TCI) obtained by smoking dura-
tion times daily amounts of smoking (0, 1-10, 11-15, 16-
20, 21-34, or 35+ pack-year). 
A potential confounder among the variables of the base-
line survey was defined as a variable showing a statistical
significance based on the crude relative risk (cRR) of lung
cancer. By this definition, the following five potential con-
founders were chosen: intake of coffee, raw fish, tomato, and
retinol, as well as the age at entry (Table 1).
The age at entry was grouped into 5-yr groups of 40-44,
45-49, 50-54, and 55-59 yr old. The frequency of coffee intake
was measured using three categories: 0, 1-6, or 7+ cups per
week. Information on consumption of raw fish, tomato, and
retinol was collected by semi-quantitative, food frequency
methods. After converting to gram equivalents, the covariates
with an unknown cut-off value were categorized according
to quartile.
Statistical methods
Total person-years were calculated by determining the num-
ber of days from the start of follow-up, January 1, 1993, until
the date of all cancer diagnosis, death from another cause, or
the end of follow-up, December 31, 2002, after which the
number of days was converted to years. 
The adjusted relative risks (aRR) of variables of smoking
habits were calculated using the Cox proportional hazards reg-
ression adjusted for potential confounders. The proportional
Variables cRR 95% CI
Incidents
(n=78)
Person-years
(125,053)
p-value
(
2
trend)
Age at entry <0.0001
40-44 11 43 407 1.0
45-49 16 36 591 1.73 [0.80, 3.73]
50-54 30 30 695 3.87 [1.94, 7.73]
55-59 21 14 360 5.82 [2.81, 12.07]
Age at last follow-up 0.54
-54 22 34 391 1.0
55-59 17 37 708 0.70 [0.38, 1.33]
60-64 26 33 905 1.25 [0.71, 2.19]
65- 13 19 049 0.98 [0.49, 1.99]
Coffee intakes (times/week) 0.02
0 11 29 020 1.0
1-6 11 24 212 1.14 [0.50, 2.58]
7+ 56 70 800 1.95 [1.04, 3.63]
Raw fish intake 0.03
Q1 33 42 175 1.0
Q2 10 14 019 0.89 [0.40, 1.99]
Q3 15 31 505 0.88 [0.46, 1.68]
Q4 13 31 116 1.09 [0.64, 1.86]
Tomato intake 0.01
Q1 30 31 930 1.0
Q2 11 21 131 0.56 [0.29, 1.11]
Q3 16 24 463 0.71 [0.39, 1.28]
Q4 16 41 456 0.42 [0.23, 0.76]
Retinol intake 0.04
Q1 29 31 106 1.0
Q2 15 31 116 0.52 [0.28, 0.96]
Q3 20 31 449 0.68 [0.38, 1.20]
Q4 14 31 382 0.48 [0.25, 0.91]
Table 1. Crude relative risks (cRR) and their 95% confidence
intervals (CI) of lung cancer by potential confounders*
*Excluding missing data. Fig. 1. Flow chart of the design and process.
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hazards assumption was examined by preparing log (-log) plots
of the survival function. Confidence intervals were obtained
by the Wald method and all reported p-values are two sided.
The chi-square test for trend was used to evaluate linear trends.
Analyses were conducted using STATA version 8 (15).
RESULTS
During the total 125,053 person-years of follow-up, 78
newly diagnosed cases of lung cancer were identified from
the 14,272 study participants. Table 1 gives the results of
univariate analysis for potential confounders including age at
entry. While there was a statistical difference between groups
by age at entry, intake of coffee showed a positive significant
association and dose-response relationship. The cRR of intake
of raw fish, tomato, and retinol indicated their protective value.
Table 2 shows the cRR of four variables related to smoking
habits-smoking status, duration of smoking, amounts of daily
smoking, and TCI. The cRR of current smokers, duration of
smoking over 31 yr, amounts of daily smoking over 31 ciga-
rettes, and the total cigarette index over 35 pack-year were
5.12, 16.05, 6.31, and 13.25, respectively. In other words,
current smokers, a longer duration of smoking, larger amounts
of daily smoking, or a higher total cigarette index exhibited
higher risk of lung cancer.
When age at entry, intake of coffee, raw fish, tomato, and
retinol were controlled as potential confounders based on the
results of Table 1, the aRR in current smokers, duration of
smoking over 31 yr, amounts of daily smoking over 31 ciga-
rettes, and total cigarette index over 35 pack-year were 4.18,
6.97, 4.79, and 8.55, respectively (Table 3). These observa-
tions were interpreted that four variables of smoking habits
showed the statistical significance and dose-response relation-
ship even after adjusted for confounders.
DISCUSSION
It is important to identify factors that influence a smoker’s
risk of developing lung cancer in order to better understand
the etiology of the disease, and to more effectively target high-
risk individuals for prevention and screening interventions.
The etiological role of cigarette smoking in inducing lung
cancer has been well known since the early 1950s and con-
stitutes the largest body of scientific evidence on the carcino-
genic effects in humans from exposure to chemicals (5). In
addition to the fact that about 90% of cases are thought to
be tobacco-related (16), there is a clear dose-response relation-
ship between lung-cancer risk and the number of cigarettes
smoked per day, degree of inhalation, and age at initiation
of smoking (17, 18). While the risk estimates for lung can-
cer reported by the large cohort studies range approximately
Variables cRR 95% CI
Incidents
(n=78)
Person-years
(125,053)
p-value
(
2
trend)
Smoking status <0.0001
Never 5 27 918 1.0
Past 11 33 077 1.53 [0.56, 4.22]
Current 62 61 540 5.12 [2.21, 11.82]
Duration of smoking <0.0001
0 5 32 877 1.0
-10 1 6 702 0.98 [0.12, 8.40]
-20 6 14 829 2.67 [0.82, 8.71]
-30 20 45 150 2.91 [1.09, 7.76]
31+ 46 25 495 11.91 [4.73, 29.98]
Amounts of daily smoking <0.0001
0 6 31 869 1.0
-10 0 10 770 - -
-20 22 33 100 3.53 [1.43,  8.71]
-30 37 38 335 5.13 [2.17, 12.16]
31+ 13 10 979 6.31 [2.39, 16.59]
Total cigarette Index (pack-year) <0.0001
0 5 29 631 1.0
1-10 6 18 869 1.90 [0.61, 5.90]
11-15 5 12 063 2.48 [0.76, 8.13]
16-20 9 13 637 3.95 [1.41, 11.10]
21-34 24 31 888 4.51 [1.84, 11.03]
35+ 28 12 690 13.25 [5.49, 32.01]
Table 2. Crude relative risks (cRR) and their 95% confidence
intervals (CI) of lung cancer by smoking habits*
*Excluding missing data.
Variables aRR 95% CI
p-value
(
2
trend)
Smoking status 0.0001
Never 1.0
Past 0.99 [0.33, 2.96]
Current 4.18 [1.78, 9.81]
Duration of smoking <0.0001
0 1.0
-10 1.06 [0.12, 9.10]
-20 2.38 [0.68, 8.29]
-30 2.28 [0.82, 6.38]
31+ 6.97 [2.70, 17.9]
Amounts of daily smoking 0.0002
0 1.0
-10 - -
-20 2.85 [1.14, 7.17]
-30 3.99 [1.65, 9.63]
31+ 4.79 [1.75, 13.1]
Total cigarette Index (pack-year) <0.0001
0 1.0
1-10 1.76 [0.54, 5.77]
11-15 1.99 [0.56, 7.10]
16-20 3.16 [1.06, 9.46]
21-34 3.20 [1.27, 8.08]
35+ 8.55 [3.46, 21.1]
Table 3. Adjusted relative risks (aRR) and their 95% confidence
intervals (CI) of lung cancer* 
*Adjusted for intake of coffee, raw fish, tomato, and retinol as well as age
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between 7 and 15 (19, 20), the relative risk from this study
was 4.18.
Such a large heterogeneity of results was considered to be
associated with three major sources of variation: factors inher-
ent to the studies such as study design, response rates, and
statistical power; characteristics of smoking habits in the dif-
ferent population studies; and differential distribution of con-
founders and effect modifiers (21). First of all, the interpre-
tation of results should involve the study design because the
apparent decrease of the ORs is related to the artefact of the
relative risk comparison, which tends to mask the freezing
of the absolute risk at the time of quitting smoking. Second
issue as various smoking habits in the different population
would be related with the fact that Asian men has a lower
number of cigarette smoked per day rather than Western men
and the prevalence of smoking began to rise in the 1960s
and 1970s (6). Based on these backgrounds, the effect of smok-
ing is consistently lower in Asian countries than in studies
of smokers in several western countries (16, 19). The final
issue about differential distribution of confounders and effect
modifiers could be considered by various risk estimates of
previous studies in Korean men. While the RR of Jee et al.
(6) and Yun et al. (7) were 4.0 (95% CI: 3.5-4.4) and 3.83
(95% CI: 2.97-4.94), respectively, these studies were con-
ducted using secondary databases. In other words, the two
studies used the data collected as part of an insurance plan
so that the validity of self-reported smoking information was
suspected of doubt and the adjustment for confounders or
effect modifiers should be limited (6). On the other hand,
this study used the primary database constructed to investi-
gate risk factors of major cancers in Korean men. In addition
to the merit above, this study assessed the incidence of lung
cancer. If a study was based on cancer mortality data, the effect
of smoking on the cancer incidence might have been con-
founded by its effect on other fatal diseases, such as cardio-
vascular disease (22).
In spite of these strengths, this study had some limitations.
Firstly, the cohort participants were restricted as men aged
between 40 and 59 yr-old at entry. Because of this reason, age
at the latest follow-up was not different according to occur-
ring lung cancer. The inference of results should be restrict-
ed for middle-aged men. Secondly, a chance of misclassifica-
tion of grouping in self-reported smoking habits could not
be excluded even if the validity studies were done at cohort
constructed. Especially, we disclosed a never smoker in the
questionnaire as a total consumption in the whole life of less
than 20 cigarettes, but misclassification of current smokers
as never smokers in this study could result in an underesti-
mated cancer risk.
In conclusion, this study reconfirmed that smoking increas-
es the risk of lung cancer in middle aged Korean men by
4.18-fold. Because the health burden from smoking-related
lung cancer among Korean men will increase in the near
future, anti-smoking program should be done strongly.
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